-
Wake Up to Nocturia Studies Reinforce Serious Associated Risk of Nocturia
in Uncategorized amStudy results discussed today at the European Association of Urology (EAU) Congress in Barcelona, have reinforced the association between nocturia and a greater risk of falls and mortality…
-
Xanodyne and Ferring announce co-promote for ZIPSOR™
in Uncategorized amXanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women’s healthcare and pain management…
-
FIRMAGON® has a significantly greater probability of PSA recurrence-free survival than leuprolide in prostate cancer patients
in Uncategorized amResults from a phase III pivotal study sub-analyses reported in European Urology show that…
-
Launch of FIRMAGON
in Uncategorized amLaunch of FIRMAGON® (degarelix), a GnRH blocker for advanced hormone-dependent prostate cancer.
0 -
Ferring donates $3 million to the Royal Textile Academy of Bhutan
in Uncategorized amFrederik Paulsen, Chairman, Ferring Pharmaceuticals, announced a $3 million donation to the Royal Textile Academy of Bhutan…
-
Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) 2010 Theme Announced
in Uncategorized amFerring Pharmaceuticals is proud to announce the second Ferring Research Infertility and Gynaecology GrAnt (FRIGGA) today…
-
New Data Supports Significant Economic and Clinical Value of MENOPUR® in IVF
in Uncategorized amNew data from an economic analysis presented today at this year’s European Society of Human Reproduction and Embryology (ESHRE) congress showed that…
-
Ferring launches New International Fertility Media Award (FIMA) 2010
in Uncategorized amFerring is proud to announce the launch of its first Fertility Media Award (FIMA) today during the 25th Annual Society of Human Reproduction and Embryology (ESHRE) congress…
-
Ferring Pharmaceuticals announces new Board Member
in Uncategorized amFerring Pharmaceuticals announced today that Dr. John Patterson CBE FRCP has been appointed as a new Board Member with immediate effect…
-
Frost & Sullivan Accolade for Ferring Pharmaceuticals
in Uncategorized amThe 2008 Frost & Sullivan European Human Growth Hormone Competitive Strategy Leadership Award is presented to Ferring Pharmaceuticals…
Uncategorized
Uncategorized
